Advanced Medical Solutions (AQA) AI Stock Analysis

Advanced Medical Solutions

(Frankfurt:AQA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Recurring medical consumables modelAMS sells consumable products used repeatedly in routine wound care and surgical procedures, creating a recurring revenue foundation rather than relying mainly on infrequent equipment purchases. This supports ongoing customer demand and provides a durable platform for serving hospital and community-care channels.

Negative Factors

Material margin compressionThe sharp decline in net and EBIT margins shows that revenue growth is translating into substantially less profit than in 2021–2022. Persistently weaker profitability could limit reinvestment, reduce the benefit of scale, and leave earnings more exposed to cost pressure or unfavorable product mix.

Advanced Medical Solutions (AQA) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 611.34M
Dividend Yield: 1.56%
Average Volume (3M): 798
Price to Earnings (P/E): 166.2
Beta (1Y): 0.41
Revenue Growth: 2.56%
EPS Growth: -61.19%
Country: Germany
Employees: 1,800
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

Advanced Medical Solutions Business Overview & Revenue Model

Company Description

Advanced Medical Solutions Group plc (AMS), along with its subsidiaries, specializes in the innovation, production, and worldwide distribution of advanced medical solutions. Its primary markets include wound treatment, surgical procedures, and wound...

Advanced Medical Solutions Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:AQA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:TSTL	80Outperform	GBP 194.70M	24.28	23.05%	3.51%	10.02%	19.83%
GB:CTEC	71Outperform	GBP 4.67B	51.64	8.40%	2.28%	1.94%	-43.71%
GB:NIOX	68Neutral	GBP 273.94M	40.48	10.01%	2.29%	3.26%	32.54%
GB:SPI	64Neutral	GBP 1.00B	-529.79	-0.26%	0.60%	1.97%	-110.22%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:PRTC	50Neutral	GBP 287.84M	157.27	0.14%	―	-4.11%	-96.92%

* Healthcare Sector Average

Performance Comparison

DE:AQA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:AQA	Advanced Medical Solutions	3.36	0.96	40.18%
GB:NIOX	Circassia Pharmaceuticals	67.60	1.31	1.98%
GB:CTEC	ConvaTec Group plc	244.40	11.17	4.79%
GB:PRTC	PureTech Health	117.40	-12.40	-9.55%
GB:SPI	Spire Healthcare	249.00	17.58	7.60%
GB:TSTL	Tristel plc	405.00	58.67	16.94%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Advanced Medical Solutions AI Stock Analysis